Lack of efficacy of dupilumab in the treatment of keloid disorder.

Autor: Tirgan MH; Keloid Research Foundation, New York, NY, USA., Uitto J; Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Joan and Joel Rosenbloom Center for Fibrotic Diseases, Thomas Jefferson University, Philadelphia, PA, USA.
Jazyk: angličtina
Zdroj: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Feb; Vol. 36 (2), pp. e120-e122. Date of Electronic Publication: 2021 Oct 02.
DOI: 10.1111/jdv.17669
Databáze: MEDLINE